HOME >> MEDICINE >> NEWS
Antibiotic treatment successful against elephantiasis

A single course of one antibiotic can successfully treat elephantiasis (filariasis)--a parasitic worm disease that is one of the most common causes of global disability, concludes a study published in this week's issue of THE LANCET.

Bancroftian filariasis is a disease characterised by severe and debilitating swelling of the limbs. The search for compounds active against the causative organism, Wuchereria bancrofti adult worms, has so far failed to deliver a radical curative treatment. The antifilarial drugs currently used, diethylcarbamazine and ivermectin, are predominantly active against the larval offspring of the parasite. These treatments form the basis of global programmes used to eliminate lymphatic filariasis. However, drugs with adult worm activity could greatly improve the prospects of programme closure.

Mark Taylor (Liverpool School of Tropical Medicine, Liverpool, UK) and colleagues tested whether treatment against Wolbachia--a bacterium the adult worms are dependent on--could be effective for filariasis. They recruited 72 men infected with W bancrofti from Kimang'a village, Pangani, Tanzania, aged 1568 years. Half were assigned to placebo and half to an 8-week course of the antibiotic doxycycline. They found that doxycycline treatment resulted in almost complete elimination of adult worms 14 months after treatment and a sustained loss of larval offspring from at least 8 to 14 months after treatment.

Dr Taylor concludes: "In our study, an 8-week course of doxycycline against W bancrofti induced both sustained reductions in the larval offspring and, most notably, the adult worm activity. This is especially important since the adult worms cause the disease pathology in lymphatic filariasis and no safe, effective treatment against adult worms existsHowever, an 8-week course of doxycycline treatment is not applicable to mass treatment strategies because of both the logistical difficulties of delivering long-term treatments and doxyc
'"/>

Contact: Joe Santangelo
j.santangelo@elsevier.com
1-212-633-3810
Lancet
16-Jun-2005


Page: 1 2

Related medicine news :

1. Antibiotic ear drops favored over popular oral antibiotics for ear infections
2. Antibiotic proves successful in tackling symptoms of acute asthma
3. Antibiotic not sufficient for serious eye infection in communities with high disease prevalence
4. Antibiotic eardrops better than pills at treating middle ear infections
5. Antibiotics do not prevent recurrent myocardial infarcts in subjects with periodontitis
6. Antibiotics appear to have little benefit for uncomplicated lower respiratory tract infections
7. Antibiotic treatment not necessary for majority of children with conjunctivitis
8. Antibiotic might fight HIV-induced neurological problems
9. Spot on treatment for acne
10. New treatment boosts muscle function in myasthenia gravis
11. New treatment effective in counteracting cocaine-induced symptoms

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/26/2017)... ... September 26, 2017 , ... Ron Norman, CEO of ... use the Law of Large Numbers in favor of senior, upper-level executive job candidates ... casinos, have long understood the Law of Large Numbers as a way of protecting ...
(Date:9/26/2017)... ... September 26, 2017 , ... CGL Electronic Security Inc., an ... its new umbrella, CGL Technologies, LLC. , The new CGL Technologies, LLC office is ... and Jon McCormack, both of whom have creative business development methods, who are responsive ...
(Date:9/26/2017)... Galloway, N.J. (PRWEB) , ... September 26, 2017 ... ... mocktail at the shore, the John R. Elliott HERO Campaign for Designated Drivers ... Hotel & Golf Club. , Thirty-one local bars and restaurants took on the ...
(Date:9/26/2017)... (PRWEB) , ... September 26, 2017 , ... Founded as ... decades growing into an innovative leader in special education. In 2018, Glenholme will ... , Glenholme, formerly a world renowned horse farm for Hackney show ponies, was generously ...
(Date:9/26/2017)... ... September 26, 2017 , ... The 2017 American Academy of Cosmetic Surgery ... Fat,” revealed not only the latest about cosmetic procedures to remove and replace fat, ... cosmetic medicine. , “Fat really is magical, especially when it comes to the cosmetic ...
Breaking Medicine News(10 mins):
(Date:9/5/2017)... Sapheneia and Scannerside received FDA 510(k) clearance ... a third-party Vendor neutral CT product that makes it ... with current MITA standards. ... is specifically designed to provide CT operators, prior to ... over a predefined threshold. Scannerside Dose Check is intended ...
(Date:9/5/2017)... , Sept. 5, 2017  Getinge, a leading ... a vibrant charitable donation program -- "Color for ... congenital heart defect research by The Children,s Heart ... the general public are encouraged to download a ... the completed artwork to the gallery on the ...
(Date:9/5/2017)... Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ) (TASE: ... on the development of oral drug delivery systems, announced ... the U.S. Food and Drug Administration (FDA) regarding ORMD-0801, ... At the meeting, the FDA gave ... ORMD-0801, would be a Biologics License Application (BLA).  Such ...
Breaking Medicine Technology:
Cached News: